TY - JOUR
T1 - Effectiveness of plasma treatment on gastric cancer cells
AU - Torii, Koji
AU - Yamada, Suguru
AU - Nakamura, Kae
AU - Tanaka, Hiromasa
AU - Kajiyama, Hiroaki
AU - Tanahashi, Kuniaki
AU - Iwata, Naoki
AU - Kanda, Mitsuro
AU - Kobayashi, Daisuke
AU - Tanaka, Chie
AU - Fujii, Tsutomu
AU - Nakayama, Goro
AU - Koike, Masahiko
AU - Sugimoto, Hiroyuki
AU - Nomoto, Shuji
AU - Natsume, Atsushi
AU - Fujiwara, Michitaka
AU - Mizuno, Masaaki
AU - Hori, Masaru
AU - Saya, Hideyuki
AU - Kodera, Yasuhiro
N1 - Publisher Copyright:
© 2014, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2015/7/27
Y1 - 2015/7/27
N2 - Background: Treatment of peritoneal carcinomatosis arising from gastric cancer remains a considerable challenge. In recent years, the anticancer effect of nonequilibrium atmospheric pressure plasma (NEAPP) has been reported in several cancer cell lines. Use of NEAPP may develop into a new class of anticancer therapy that augments surgery, chemotherapy, and radiotherapy. Method: Gastric cancer cells were assessed for changes in cell morphology and rate of proliferation after treatment with NEAPP-exposed medium (PAM). To explore the functional mechanism, caspase 3/7, annexin V, and uptake of reactive oxygen species (ROS) were evaluated, along with the effect of the ROS scavenger N-acetylcysteine (NAC). Results: PAM treatment for 24 h affected cell morphology, suggestive of induction of apoptosis. PAM cytotoxicity was influenced by the time of exposure to PAM, the type of cell line, and the number of cells seeded. Cells treated with PAM for 2 h demonstrated activated caspase 3/7 and an increased proportion of annexin V-positive cells compared with untreated cells. Additionally, ROS uptake was observed in PAM-treated cells, whereas NAC reduced the cytotoxicity induced by PAM presumably through reduction of ROS uptake. Furthermore, CD44 variant 9, which reportedly leads to glutathione synthesis and suppresses stress signaling of ROS, was overexpressed in PAM-resistant cells. Conclusions: PAM treatment induced apoptosis of gastric cancer cells through generation and uptake of ROS. Local administration of PAM could develop into an option to treat peritoneal carcinomatosis.
AB - Background: Treatment of peritoneal carcinomatosis arising from gastric cancer remains a considerable challenge. In recent years, the anticancer effect of nonequilibrium atmospheric pressure plasma (NEAPP) has been reported in several cancer cell lines. Use of NEAPP may develop into a new class of anticancer therapy that augments surgery, chemotherapy, and radiotherapy. Method: Gastric cancer cells were assessed for changes in cell morphology and rate of proliferation after treatment with NEAPP-exposed medium (PAM). To explore the functional mechanism, caspase 3/7, annexin V, and uptake of reactive oxygen species (ROS) were evaluated, along with the effect of the ROS scavenger N-acetylcysteine (NAC). Results: PAM treatment for 24 h affected cell morphology, suggestive of induction of apoptosis. PAM cytotoxicity was influenced by the time of exposure to PAM, the type of cell line, and the number of cells seeded. Cells treated with PAM for 2 h demonstrated activated caspase 3/7 and an increased proportion of annexin V-positive cells compared with untreated cells. Additionally, ROS uptake was observed in PAM-treated cells, whereas NAC reduced the cytotoxicity induced by PAM presumably through reduction of ROS uptake. Furthermore, CD44 variant 9, which reportedly leads to glutathione synthesis and suppresses stress signaling of ROS, was overexpressed in PAM-resistant cells. Conclusions: PAM treatment induced apoptosis of gastric cancer cells through generation and uptake of ROS. Local administration of PAM could develop into an option to treat peritoneal carcinomatosis.
UR - http://www.scopus.com/inward/record.url?scp=84915814793&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84915814793&partnerID=8YFLogxK
U2 - 10.1007/s10120-014-0395-6
DO - 10.1007/s10120-014-0395-6
M3 - Article
C2 - 24997570
AN - SCOPUS:84915814793
SN - 1436-3291
VL - 18
SP - 635
EP - 643
JO - Gastric Cancer
JF - Gastric Cancer
IS - 3
ER -